CA75339A1012
© Newsfile
29.11.2025
DOSE
LISTED
CSE
Rapid Dose Announces Extension to Promissory Notes
News Preview
Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing") which closed in 2023. T...
Themefolio
Profiler
Peergroup
© Newsfile
18.11.2025
DOSE
LISTED
CSE
CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Extends NicStrip(TM) Deal with Nicotine Partner as Health Canada Reviews Product
News Preview
Toronto, Ontario--(Newsfile Corp. - November 18, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada...
Themefolio
Profiler
Peergroup
© Newsfile
20.10.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner
News Preview
Seven-month extension valued at up to approximately $1.8 million CAD supports further evaluation as RDT advances broader commercialization initiatives for NicStrip(TM)Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company developing innovative d...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
02.10.2025
DOSE
LISTED
CSE
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - October 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), and consistent with prior quarters, the Company intends to...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
29.07.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip(TM) to Combat Opiate Addiction Crisis
News Preview
Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is proud to announce the launch of a new significant harm reduction initiative aimed at addressing the devastating opioid crisis gripping Canada's First Nations communities. In colla...
Themefolio
Profiler
Peergroup
© Newsfile
22.07.2025
DOSE
LISTED
CSE
CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine
News Preview
Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and for in...
Themefolio
Profiler
Peergroup
© Newsfile
03.07.2025
DOSE
LISTED
CSE
Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees
News Preview
Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors") to issue common shares (the "Debt Shares") to such Directors in exchange for the cancellation of Director fees owing. Each of the five Direct...
Themefolio
Profiler
Peergroup
© Newsfile
03.07.2025
DOSE
LISTED
CSE
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), and consistent with prior quarters, the Company intends to issue common...
Themefolio
Profiler
Peergroup
© Newsfile
02.07.2025
DOSE
LISTED
CSE
CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study
News Preview
Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and fo...
Themefolio
Profiler
Peergroup
© Newsfile
02.06.2025
DOSE
LISTED
CSE
Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors
News Preview
Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has entered into debt settlement agreements with certain of its creditors (the "Creditors") to issue an aggregate of 1,888,237 common shares (the "Settleme...
Themefolio
Profiler
Peergroup
© Newsfile
27.05.2025
DOSE
LISTED
CSE
Rapid Dose Announces Proposed Equity Private Placement Financing
News Preview
Burlington, Ontario--(Newsfile Corp. - May 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing (the "Financing") for up to $3,000,000 of gross proceeds, consisting of up to 13,636,364 units (the "Units") at a price of $0.22 per Unit. Each Un...
Themefolio
Profiler
Peergroup
© Newsfile
27.05.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology
News Preview
Burlington, Ontario--(Newsfile Corp. - May 26, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar Oral...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
22.05.2025
DOSE
LISTED
CSE
CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Advances QuickStrip(TM) Technology for Use in Dentistry
News Preview
Toronto, Ontario--(Newsfile Corp. - May 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and for inv...
Themefolio
Profiler
Peergroup
© Newsfile
10.05.2025
DOSE
LISTED
CSE
Rapid Dose Announces Proposed Debt Settlement
News Preview
Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors") to issue up to an aggregate of 2,500,000 common shares (the "Settlement Shares") to such Creditors in exchange for the cancellation of outstanding accou...
Themefolio
Profiler
Peergroup
© Newsfile
08.04.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
News Preview
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce an update to the ongoing collaboration project with the Faculty of Kinesiology...
Themefolio
Profiler
Peergroup
© Newsfile
03.04.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada
News Preview
Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce its participation at major dental tradeshows across Canada to showcase and provide samples...
Themefolio
Profiler
Peergroup
© Newsfile
02.04.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors
News Preview
Burlington, Ontario--(Newsfile Corp. - April 1, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), and consistent with prior quarters, the Company intends to issue commo...
Themefolio
Profiler
Peergroup
© Newsfile
18.02.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing
News Preview
Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing (the "Financing") for up to $5,000,000 of gross proceeds, consisting of up to 20,833,333 common shares (the "Common Shares") at a price of $0....
Themefolio
Profiler
Peergroup
© Newsfile
29.01.2025
DOSE
LISTED
CSE
Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025
News Preview
Burlington, Ontario--(Newsfile Corp. - January 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (RDT), a Canadian biotechnology company working with an international company in oral nicotine products, is pleased to announce the expansion of their collaboration through the continuation of the exclusive pre-commercialization agreement. This agre...
Themefolio
Profiler
Peergroup
© Newsfile
27.01.2025
DOSE
LISTED
CSE
Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement
News Preview
Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated December 9, 2024 (the "Initial Press Release"), announcing a proposed debt settlement (the "Shares for Debt Transaction") with certain of its creditors (the "Creditors"...
Themefolio
Profiler
Peergroup
© Newsfile
16.01.2025
DOSE
LISTED
CSE
Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees
News Preview
Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has completed its previously announced shares for debt transaction to issue common shares (the "Debt Shares") to its non-management directors (the "Directors") in exchange for the cancell...
Themefolio
Profiler
Peergroup
© Newsfile
07.01.2025
DOSE
LISTED
CSE
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), and consistent with prior quarters, the Company intends to issue comm...
Themefolio
Profiler
Peergroup
© Newsfile
24.12.2024
DOSE
LISTED
CSE
Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees
News Preview
Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors") to issue common shares (the "Debt Shares") to such Directors in exchange for the cancellation of director fees owing. Each of the five D...
Themefolio
Profiler
Peergroup
© Newsfile
10.12.2024
DOSE
LISTED
CSE
Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement
News Preview
Burlington, Ontario--(Newsfile Corp. - December 10, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing (the "Financing") for up to $6,000,000 of gross proceeds, consisting of up to 24,000,000 units (the "Units") at a price of $0.25 per Unit....
Themefolio
Profiler
Peergroup
© Newsfile
05.12.2024
DOSE
LISTED
CSE
Rapid Dose Therapeutics Corp. Files Patent Application for Lidocaine Oral Thin Strip
News Preview
Burlington, Ontario--(Newsfile Corp. - December 5, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is pleased to announce that it has filed a patent application for its Lidocaine Oral Thin Film Strip, with the Canadian Intellectual Property Office ("CIPO").Dentists commonly perform denta...
Themefolio
Profiler
Peergroup
© Newsfile
30.10.2024
DOSE
LISTED
CSE
Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement
News Preview
Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of its previously announced equity private placement financing (the "Financing") for aggregate gross proceeds of $542,000.The proceeds of the Financing wil...
Themefolio
Profiler
Peergroup
© Newsfile
02.10.2024
DOSE
LISTED
CSE
Rapid Dose Announces Payment in Shares for Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), the Company intends to issue common shares ("Common Shares") in satis...
Themefolio
Profiler
Peergroup
© Newsfile
17.09.2024
DOSE
LISTED
CSE
Rapid Dose Provides Update on Common Share Private Placement
News Preview
Burlington, Ontario--(Newsfile Corp. - September 16, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated August 7, 2024, regarding a proposed equity private placement financing (the "Financing"), the Company has received an extension from the Canadian Securities Ex...
Themefolio
Profiler
Peergroup
© Newsfile
22.07.2024
DOSE
LISTED
CSE
Rapid Dose Announces Closing of First Tranche of Common Share Private Placement
News Preview
Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the "Financing") for aggregate gross proceeds of $309,000.The proceeds of the Financing will be used for...
Themefolio
Profiler
Peergroup
© Newsfile
03.07.2024
DOSE
LISTED
CSE
Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), the Company intends to issue common shares ("Common Shares") in satisfac...
Themefolio
Profiler
Peergroup
© Newsfile
02.07.2024
DOSE
LISTED
CSE
Rapid Dose Therapeutics Reports Fiscal Year 2024 Financial Results
News Preview
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), is pleased to announce the filing of its financial results for the year ended February 29, 2024. Mark Upsdell, Chairman and Chief Executive Officer, stated, "Over the past several years, our product roadmap has expanded f...
Themefolio
Profiler
Peergroup
© Newsfile
25.06.2024
DOSE
LISTED
CSE
Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant
News Preview
Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to announce the recent award of a Mitacs Accelerate grant, with a value of $30,000 in May 2024 in addition to $55,000 in 2023, to continue the development...
Themefolio
Profiler
Peergroup
© Newsfile
19.06.2024
DOSE
LISTED
CSE
Rapid Dose Provides Update on Common Share Private Placement
News Preview
Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 8, 2024, regarding a proposed equity private placement financing (the "Financing"), the Company has received an extension from the Canadian Securities Exchange al...
Themefolio
Profiler
Peergroup
© Newsfile
29.05.2024
DOSE
LISTED
CSE
Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application
News Preview
Burlington, Ontario--(Newsfile Corp. - May 29, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces its collaboration in the National Football League (NFL) – funded clinical trial program entitled "Naturally Produced Cannabinoids for Pain Management and Neuroprotection from Concussion and Participation in...
Themefolio
Profiler
Peergroup
© Newsfile
22.05.2024
DOSE
LISTED
CSE
Rapid Dose Therapeutics and McMaster University's Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films for Rapid Drug Delivery
News Preview
Burlington, Ontario--(Newsfile Corp. - May 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE in partnership with McMaster University ("McMaster") is pleased to announce the publication of the results of their collaborative research project titled...
Themefolio
Profiler
Peergroup
© Newsfile
04.05.2023
DOSE
LISTED
CSE
CSE Bulletin: Reinstatement - Rapid Dose Therapeutics Corp. (DOSE)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 4 mai/May 2023) - Effective immediately, Rapid Dose Therapeutics Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. _________________________________ Avec effet immédiat, Rapid Dose Therapeutics Corp. ser...
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2022
DOSE
LISTED
CSE
CSE Bulletin: Suspension - Rapid Dose Therapeutics Corp. (DOSE)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 29 août/August 2022) - Effective immediately, Rapid Dose Therapeutics Corp. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commission...
Themefolio
Profiler
Peergroup
© Newsfile
20.11.2020
DOSE
LISTED
CSE
CSE Bulletin: Reinstatement - Rapid Dose Therapeutics Corp. (DOSE)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 19 novembre/November 2020) - Effective immediately, Rapid Dose Therapeutics Corp. will be reinstated for trading. The Company has rectified the default situation that gave rise to the suspension. _________________________________ À compter de maintenant, Rapid...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
